{"transactions":[{"id":3318680,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":152542,"kind":"person","name":"BUCHEN DAVID A","position":1,"cik":"0001241751","reported_name":"BUCHEN DAVID A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Restricted Stock Units","published_at":"2020-01-06T22:20:41.000Z","date":"2020-01-03","kind":"exercise","acquired":false,"shares":27614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 3, 2019, the reporting person was granted 110,457 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.  The restricted stock units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 3, 2019, the reporting person was granted 110,457 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.  The restricted stock units do not expire."}],"balance_after":82843,"derivative":{"underlying":"Class A Common Stock","underlying_shares":27614},"source":{"system":"sec-edgar","filing":"0001723128-20-000002","document":"wf-form4_157834922391058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312820000002/wf-form4_157834922391058.xml","form_type":"4"}},{"id":3318679,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":152542,"kind":"person","name":"BUCHEN DAVID A","position":1,"cik":"0001241751","reported_name":"BUCHEN DAVID A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2020-01-06T22:20:41.000Z","date":"2020-01-03","kind":"tax_withholding","acquired":false,"shares":8188,"price":4.72,"value":38647.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":20426,"source":{"system":"sec-edgar","filing":"0001723128-20-000002","document":"wf-form4_157834922391058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312820000002/wf-form4_157834922391058.xml","form_type":"4"}},{"id":3318678,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":152542,"kind":"person","name":"BUCHEN DAVID A","position":1,"cik":"0001241751","reported_name":"BUCHEN DAVID A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2020-01-06T22:20:41.000Z","date":"2020-01-03","kind":"exercise","acquired":true,"shares":27614,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":28614,"source":{"system":"sec-edgar","filing":"0001723128-20-000002","document":"wf-form4_157834922391058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312820000002/wf-form4_157834922391058.xml","form_type":"4"}},{"id":3702068,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":152542,"kind":"person","name":"BUCHEN DAVID A","position":1,"cik":"0001241751","reported_name":"BUCHEN DAVID A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Restricted Stock Units","published_at":"2019-01-07T22:56:30.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":110457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on January 3, 2020 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on January 3, 2020 and have no expiration date."}],"balance_after":110457,"derivative":{"underlying":"Class A Common Stock","underlying_shares":110457},"source":{"system":"sec-edgar","filing":"0001723128-19-000009","document":"wf-form4_154690177391907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000009/wf-form4_154690177391907.xml","form_type":"4"}},{"id":3702067,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":152542,"kind":"person","name":"BUCHEN DAVID A","position":1,"cik":"0001241751","reported_name":"BUCHEN DAVID A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Stock Option","published_at":"2019-01-07T22:56:30.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":227273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on January 3, 2020."}],"balance_after":227273,"derivative":{"exercise_price":13.58,"expiration_date":"2029-01-03","underlying":"Class A Common Stock","underlying_shares":227273},"source":{"system":"sec-edgar","filing":"0001723128-19-000009","document":"wf-form4_154690177391907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000009/wf-form4_154690177391907.xml","form_type":"4"}}]}